Humacyte

Humacyte

HUMA· Manufacturing· Fiscal year ends in December

CEO pay in FY2024Stock +77.8% in FY2024

Laura E. Niklason is the CEO of Humacyte and was paid $905.4K in FY2024 (Dec).

Pay$100 in the stock at the end of FY21 → $52
CEO pay is from each Humacyte proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Laura E. NiklasonFY2024
  2. 2Dale A. SanderFY2024
  3. 3Shamik J. ParikhNot disclosed

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Humacyte paid its 3 named executives $2.3M in total in FY2024 (Dec). CEO Laura E. Niklason was paid $905.4K of that.

Name
Laura E. NiklasonPresident and Chief Executive Officer
Dale A. SanderChief Financial Officer, Chief Corporate Development Officer and Treasurer

of each named executive, from the Summary Compensation Table of each proxy.

Peers17

See all

The FY2025 (Dec) proxy of Humacyte names 17 peer companies for pay. Among Humacyte and these peers, CEO pay was 7th highest of 12 and total shareholder return was 9th highest of 12.

7th highest of 12in Humacyte and its pay peers, FY2025 (Dec) by CEO pay:

$2.4M$33.3M

9th highest of 12in Humacyte and its pay peers, FY2025 (Dec) by total shareholder return:

$18$487

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board4

See all
  • Brady W. DouganDirector · 4 yr on the boardNot independent—Paid as an executive
  • Emery N. BrownDirector · 4 yr on the boardIndependentNominating and Governance—Paid as an executive
  • Max WallaceDirector · 4 yr on the boardIndependentCompensation, Nominating and Governance (Chair)—Paid as an executive
  • Michael T. ConstantinoDirector · 4 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive

The board of the latest proxy (FY2025).

Activity

Filings6

See all
Proxy statementDEF 14AApr 28, 2026FY2025
Annual report10-KMar 27, 2026FY2025
Proxy statementDEF 14AApr 29, 2025FY2024
Annual report10-KMar 31, 2025FY2024
Proxy statementDEF 14AApr 29, 2024FY2023
Annual report10-KMar 28, 2024FY2023